➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Harvard Business School
McKinsey
Express Scripts
Boehringer Ingelheim

Last Updated: April 18, 2021

DrugPatentWatch Database Preview

SEVELAMER CARBONATE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Sevelamer Carbonate patents expire, and when can generic versions of Sevelamer Carbonate launch?

Sevelamer Carbonate is a drug marketed by Aurobindo Pharma Ltd, Dr Reddys Labs Ltd, Impax, Amneal Pharms Co, Anxin, Impax Labs Inc, Invagen Pharms, Mylan, Rising, Twi Pharms, and Zydus Pharms. and is included in thirteen NDAs.

The generic ingredient in SEVELAMER CARBONATE is sevelamer carbonate. There are thirty-two drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the sevelamer carbonate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Sevelamer Carbonate

A generic version of SEVELAMER CARBONATE was approved as sevelamer carbonate by AUROBINDO PHARMA LTD on June 13th, 2017.

  Start Trial

Summary for SEVELAMER CARBONATE
Drug patent expirations by year for SEVELAMER CARBONATE
Drug Prices for SEVELAMER CARBONATE

See drug prices for SEVELAMER CARBONATE

Recent Clinical Trials for SEVELAMER CARBONATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Shanghai Alebund Pharmaceuticals LimitedPhase 2
Akebia TherapeuticsPhase 1
Shandong Weigao Panion Pharmaceutical Co. Ltd.Phase 3

See all SEVELAMER CARBONATE clinical trials

Pharmacology for SEVELAMER CARBONATE
Paragraph IV (Patent) Challenges for SEVELAMER CARBONATE
Tradename Dosage Ingredient NDA Submissiondate
RENVELA FOR SUSPENSION;ORAL sevelamer carbonate 022318 2009-12-30
RENVELA TABLET;ORAL sevelamer carbonate 022127 2008-12-04

US Patents and Regulatory Information for SEVELAMER CARBONATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd SEVELAMER CARBONATE sevelamer carbonate FOR SUSPENSION;ORAL 207624-001 Jun 13, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
Amneal Pharms Co SEVELAMER CARBONATE sevelamer carbonate TABLET;ORAL 207288-001 Nov 28, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
Dr Reddys Labs Ltd SEVELAMER CARBONATE sevelamer carbonate FOR SUSPENSION;ORAL 210464-001 Oct 25, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Invagen Pharms SEVELAMER CARBONATE sevelamer carbonate TABLET;ORAL 203860-001 Oct 26, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
Anxin SEVELAMER CARBONATE sevelamer carbonate TABLET;ORAL 212970-001 Apr 9, 2020 DISCN No No   Start Trial   Start Trial   Start Trial
Zydus Pharms SEVELAMER CARBONATE sevelamer carbonate TABLET;ORAL 207759-001 Aug 11, 2020 AB RX No No   Start Trial   Start Trial   Start Trial
Rising SEVELAMER CARBONATE sevelamer carbonate TABLET;ORAL 204451-001 Nov 29, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Colorcon
Harvard Business School
Johnson and Johnson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.